Countouriotis Athena

CIK 0001571469

President & CEODirector

Filings

Latest May 21, 2026

Issuers covered

Showing

14 of 14

Page 1

Track record

Realized signed returns on open-market buys and sales

No scored trades yet for Countouriotis Athena. Track record appears once open-market purchases or sales reach the +30 day horizon.

Companies where Countouriotis Athena has filed

Ticker	Issuer	Filings	Last filed
IOVA	Iovance Biotherapeutics, Inc.	5	Jun 17, 2025
PASG	Passage Bio, Inc.	5	May 21, 2026
BMRN	Biomarin Pharmaceutical Inc	3	May 22, 2025
TPTX	Turning Point Therapeutics, Inc.	1	Feb 11, 2022

14 Form 4 / 4-A filings, newest first

Filed	Issuer	Top transaction	Shares	Price	Value
May 21, 2026	PASGPassage Bio, Inc.	Holdings only	-	-	-
Jun 17, 2025	IOVAIovance Biotherapeutics, Inc.	Holdings only	-	-	-
May 30, 2025	PASGPassage Bio, Inc.	Holdings only	-	-	-
May 22, 2025	BMRNBiomarin Pharmaceutical Inc	AGrant	6,650	$0.00	$0
Jun 13, 2024	IOVAIovance Biotherapeutics, Inc.	Holdings only	-	-	-
May 23, 2024	BMRNBiomarin Pharmaceutical Inc	AGrant	4,720	$0.00	$0
May 23, 2024	PASGPassage Bio, Inc.	Holdings only	-	-	-
Mar 5, 2024	IOVAIovance Biotherapeutics, Inc.	Holdings only	-	-	-
Dec 28, 2023	BMRNBiomarin Pharmaceutical Inc	AGrant	2,180	$0.00	$0
Jun 8, 2023	IOVAIovance Biotherapeutics, Inc.	Holdings only	-	-	-
May 26, 2023	PASGPassage Bio, Inc.	Holdings only	-	-	-
Jun 14, 2022	IOVAIovance Biotherapeutics, Inc.	Holdings only	-	-	-
May 31, 2022	PASGPassage Bio, Inc.	Holdings only	-	-	-
Feb 11, 2022	TPTXTurning Point Therapeutics, Inc.	SSale	2,971	$36.30	$107,847

Showing 1-14 of 14

Page 1 of 1

Real-time Form 4 intelligence. Smarter insider tracking.